Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

Author:

Vourli Georgia1ORCID,Noori Teymur2,Pharris Anastasia2,Porter Kholoud3,Axelsson Maria4,Begovac Josip5,Cazein Francoise6,Costagliola Dominique7,Cowan Susan8,Croxford Sara9,d’Arminio Monforte Antonella10,Delpech Valerie9,Díaz Asunción11,Girardi Enrico12,Gunsenheimer-Bartmeyer Barbara13,Hernando Victoria11,Leierer Gisela14,Lot Florence6,Nunez Olivier11,Obel Niels15,Op de Coul Eline16,Paraskeva Dimitra17,Patrinos Stavros17,Reiss Peter1819,Schmid Daniela20,Sonnerborg Anders21,Suligoi Barbara22,Supervie Virginie7,van Sighem Ard18,Zangerle Robert14,Touloumi Giota1,

Affiliation:

1. Medical School, National and Kapodistrian University of Athens, Athens, Greece

2. European Centre for Disease Prevention and Control, Solna, Sweden

3. University College London, London, United Kingdom

4. Public Health Agency of Sweden, Solna, Sweden

5. Department of Infectious Diseases, School of Medicine, University of Zagreb, Zagreb, Croatia

6. Santé publique France, the French national public health agency, Saint-Maurice, France

7. Sorbonne Université, INSERM, Institut Pierre Louis d’Épidémiologie et de Santé Publique, Paris, France

8. Statens Serum Institut, Copenhagen, Denmark

9. Public Health England, London, United Kingdom

10. ASST Santi Paolo e Carlo University Hospital, Milan, Italy

11. Centro Nacional de Epidemiologia, Instituto de Salud Carlos III, Madrid, Spain

12. Istituto Nazionale Malattie Infettive ‘L. Spallanzani, Roma, Italy

13. Robert Koch Institute, Berlin, Germany

14. Medical University Innsbruck, Innsbruck, Austria

15. Rigshospitalet, Copenhagen University, Copenhagen, Denmark

16. National Institute for Public Health and the Environment, Bilthoven, The Netherlands

17. Hellenic Center for Disease Control and Prevention, Amarousio, Greece

18. Stichting HIV Monitoring, Amsterdam, The Netherlands

19. Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands

20. Austrian Agency for Health and Food Safety, Vienna, Austria

21. Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden

22. National AIDS Unit, Istituto Superiore di Sanita, Rome, Italy

Abstract

Abstract Background High uptake of antiretroviral treatment (ART) is essential to reduce human immunodeficiency virus (HIV) transmission and related mortality; however, gaps in care exist. We aimed to construct the continuum of HIV care (CoC) in 2016 in 11 European Union (EU) countries, overall and by key population and sex. To estimate progress toward the Joint United Nations Programme on HIV/AIDS (UNAIDS) 90-90-90 target, we compared 2016 to 2013 estimates for the same countries, representing 73% of the population in the region. Methods A CoC with the following 4 stages was constructed: number of people living with HIV (PLHIV); proportion of PLHIV diagnosed; proportion of those diagnosed who ever initiated ART; and proportion of those ever treated who achieved viral suppression at their last visit. Results We estimated that 87% of PLHIV were diagnosed; 92% of those diagnosed had ever initiated ART; and 91% of those ever on ART, or 73% of all PLHIV, were virally suppressed. Corresponding figures for men having sex with men were: 86%, 93%, 93%, 74%; for people who inject drugs: 94%, 88%, 85%, 70%; and for heterosexuals: 86%, 92%, 91%, 72%. The proportion suppressed of all PLHIV ranged from 59% to 86% across countries. Conclusions The EU is close to the 90-90-90 target and achieved the UNAIDS target of 73% of all PLHIV virally suppressed, significant progress since 2013 when 60% of all PLHIV were virally suppressed. Strengthening of testing programs and treatment support, along with prevention interventions, are needed to achieve HIV epidemic control.

Funder

Austrian Agency for Health and Food Safety

European Centre for Disease Prevention and Control

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3